I set up a Mastodon account (@ksoltys@twit.social) soon after Elon Musk took over Twitter and have been using it happily since. Late last year, I joined Bluesky (@ksoltys.bsky.social) though I still prefer Mastodon. That's largely because of the maturity of Mastodon's feature set and the availability of good third-party Android clients. I currently use the default Mastodon web client but on Android I use Fedilab.
As for Threads, I won't have anything to do with it. I'm trying to reduce my usage of Facebook and I expect it to become less congenial now that Musk has abolished what little fact-checking it has.
Engadget has published an article comparing Bluesky and Threads that's worth reading if you are considering joining either of the platforms or are already a user. One of the major differences is content moderation.
"“Moderation is in many ways, like governance,” Bluesky CEO Jay Graber told me earlier this year. “And setting the norms of a social space, we don't think one person or one company should be unilaterally deciding that for an entire ecosystem where people are having public conversations important to the state of the world.”
That philosophy plays out in other important ways. Twitter was never a major source of traffic for most publishers, even before Elon Musk’s takeover. But the platform once played a vital role in the news ecosystem. At a time when Elon Musk has acknowledged that X penalizes posts with links and Threads’ top exec has said that Meta doesn’t want to “encourage” hard news, Bluesky’s leaders have actually tried to foster link sharing, and several publishers have reported seeing significantly more traffic from Bluesky, compared with Threads and X."
I do wish Bluesky would give us the option to resume sessions at the last post viewed (an option available in some clients including Fedilab for Android). This makes Bluesky less convenient to use. I will be looking for a good third-party client for Android when I have some spare time.
For now, I still prefer Mastodon.
No comments:
Post a Comment